Analyst Price Target is $20.00
▲ +104.50% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Shattuck Labs in the last 3 months. The average price target is $20.00, with a high forecast of $28.00 and a low forecast of $12.00. The average price target represents a 104.50% upside from the last price of $9.78.
Current Consensus is
Buy
The current consensus among 2 investment analysts is to buy stock in Shattuck Labs. This Buy consensus rating has held steady for over two years.
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
Read More